Marest Capital’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Sell
3,115
-1,149
-27% -$407K 0.62% 12
2026
Q1
$1.37M Buy
4,264
+2,306
+118% +$687K 0.79% 11
2025
Q4
$506K Sell
1,958
-7
-0.4% -$1.59K 0.28% 20
2025
Q3
$446K Buy
1,965
+43
+2% +$8.81K 0.27% 20
2025
Q2
$402K Buy
1,922
+171
+10% +$32.9K 0.31% 13
2025
Q1
$341K Buy
1,751
+69
+4% +$14.3K 0.28% 18
2024
Q4
$380K Buy
1,682
+26
+2% +$5.8K 0.31% 16
2024
Q3
$345K Sell
1,656
-28
-2% -$5.63K 0.29% 16
2024
Q2
$317K Hold
1,684
0.28% 15
2024
Q1
$311K Buy
1,684
+10
+0.6% +$1.86K 0.29% 20
2023
Q4
$304K Buy
+1,674
New +$290K 0.31% 16

Other funds holding MSGS

Marest Capital's MSGS Position: Q2 2026 in Review

Marest Capital reduced its Madison Square Garden (MSGS) stake by 27% in Q2 2026, selling an estimated $407K and leaving 3,115 shares worth $1.25M. The position accounts for 0.62% of the portfolio, ranked #12.

Marest Capital first reported a position in MSGS in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.37M in Q1 2026. 469 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • Marest Capital held 3,115 shares of Madison Square Garden worth $1.25M as of Q2 2026.
  • Marest Capital sold 1,149 Madison Square Garden shares in Q2 2026, an estimated $407K.
  • Madison Square Garden made up 0.62% of Marest Capital's portfolio in Q2 2026, its #12 holding.
  • Marest Capital first reported a position in Madison Square Garden in Q4 2023 and has held it in 11 quarters since.
  • Marest Capital's Madison Square Garden position peaked at $1.37M in Q1 2026.
  • 469 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on Marest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.